Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $14.87 $19.38 Friday, 10th May 2024 RGNX stock ended at $15.44. This is 1.53% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 10.42% from a day low at $14.87 to a day high of $16.42.
90 days $14.87 $28.80
52 weeks $11.83 $28.80

Historical REGENXBIO Inc. prices

Date Open High Low Close Volume
Dec 15, 2023 $20.82 $21.34 $19.74 $19.96 899 656
Dec 14, 2023 $20.60 $21.38 $20.48 $20.82 588 143
Dec 13, 2023 $19.01 $20.29 $18.75 $20.15 403 703
Dec 12, 2023 $19.28 $19.31 $18.20 $19.14 421 585
Dec 11, 2023 $19.67 $19.67 $19.02 $19.39 180 233
Dec 08, 2023 $20.59 $20.59 $19.57 $19.58 213 215
Dec 07, 2023 $19.78 $20.64 $19.77 $20.60 391 123
Dec 06, 2023 $19.82 $20.14 $19.61 $19.78 221 008
Dec 05, 2023 $19.83 $19.92 $19.52 $19.62 269 599
Dec 04, 2023 $19.66 $20.28 $19.50 $20.01 369 546
Dec 01, 2023 $19.45 $19.82 $19.16 $19.67 351 561
Nov 30, 2023 $18.78 $20.00 $18.50 $19.52 464 559
Nov 29, 2023 $19.30 $19.89 $18.55 $18.61 394 128
Nov 28, 2023 $19.17 $19.36 $18.74 $19.22 182 271
Nov 27, 2023 $19.45 $19.45 $18.64 $19.19 269 586
Nov 24, 2023 $19.18 $19.63 $19.14 $19.50 98 354
Nov 22, 2023 $20.19 $20.24 $18.97 $19.13 255 252
Nov 21, 2023 $19.78 $20.23 $19.54 $19.90 355 070
Nov 20, 2023 $19.65 $20.87 $19.57 $20.03 574 748
Nov 17, 2023 $18.95 $19.53 $18.65 $19.49 448 034
Nov 16, 2023 $19.11 $19.24 $18.66 $18.86 571 874
Nov 15, 2023 $18.98 $19.54 $18.98 $19.14 579 438
Nov 14, 2023 $18.54 $19.14 $18.45 $19.05 785 026
Nov 13, 2023 $17.80 $17.91 $17.33 $17.74 1 049 352
Nov 10, 2023 $17.04 $18.24 $16.75 $17.84 838 270
Click to get the best stock tips daily for free!

About REGENXBIO Inc.

REGENXBIO. REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, wh... RGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT